September 2016 - IOZK

Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma

2016-09-29/in Dendritic Cells, Glioblastoma, International Publications /von 2016-09-29 / Cancer Immunol. Immunother. 2016 12;65(12):1499-1509

Induction of Immune Response after Allogeneic Wilms‘ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse

2016-09-12/in Acute Leukemia, Dendritic Cells, International Publications /von 2016-09-12 / Biol. Blood Marrow Transplant. 2016 12;22(12):2149-2154

1. Tumor-immunologische Symposium, Universität Leuven

2016-09-10/in Externe Meldungen, IOZK bei Fachtagungen /von IOZK